Elaborate, a lab results tool integrated with Epic and more than 65 other EHR systems, raised $10 million in its seed financing round.
Launched in 2021, the company aims to reduce the unnecessary communications between clinicians and patients by providing contextualized lab results and action items. Tusk Venture Partners led the financing round, according to a Jan. 26 Elaborate news release.
The tool is designed to help clinicians comply with the medical record-sharing stipulations of the 21st Century Cures Act.
"What the team at Elaborate has been able to do for their clients, including my practice, is nothing short of remarkable," Amy Esposito, MD, Elaborate medical advisory board member and medical director of New York City-based Reside Health, said in the release. "Because they're plugged into the EHR, they use all of the information in the patient's chart to summarize the key findings and help them schedule a billable follow-up visit if necessary. Plus they customize everything in our clinical protocols for us."